To see original article, click here
For Immediate Release
HALIFAX, Dec 1, 2016 – Tom Lynch, Chair of Precision BioLogic’s Board of Directors, is pleased to announce the appointment of Paul Empey as President and CEO of the company.
Most recently Precision BioLogic’s Executive Vice President, Empey joined the organization in 2015, bringing with him more than 30 years of experience in senior and executive positions at several successful organizations including Ocean Nutrition Canada, which is now part of Royal DSM.
Hailing originally from Boston, Empey has been helping Canadian organizations reach their potential for more than two decades. As President and CEO, he will play an active role in Precision BioLogic’s strategic direction, working closely with the board and senior management team.
Empey is pleased to have the opportunity to further develop Precision BioLogic.
“2016 saw a lot of exciting activity, including our humanitarian aid donation to the University Teaching Hospital in Yaoundé, Cameroon. Our donation made Precision BioLogic the first diagnostics company to support the World Federation of Hemophilia’s efforts to close the gap in care between those with bleeding disorders who receive proper diagnosis and treatment and those who do not,” he explains. “2017 promises to be equally exciting as we celebrate the 25th anniversary of cryocheck™, our line of frozen diagnostic products for coagulation testing,” he adds.
About Precision BioLogic
Precision BioLogic is a privately-held company that develops, manufactures and markets specialized products used by medical professionals and researchers around the globe to diagnose coagulation disorders and develop new products to improve patient outcomes. For more information, visit www.precisionbiologic.com.
– 30 –
For more information, contact:
Elaine Benoit, Precision BioLogic